Young and recent-onset injecting drug users are at higher risk for HIV
- PMID: 9519489
Young and recent-onset injecting drug users are at higher risk for HIV
Abstract
Aims: To determine whether young or recent-onset injecting drug users (IDUs) are at increased risk of HIV infection, and to compare trends in risk behaviours and HIV incidence among subgroups of IDUs.
Design: Associations of age and onset of injecting with HIV prevalence and injecting risk behaviours were determined among current IDUs who entered an Amsterdam cohort between 1989 and 1995, and compared with current IDUs recruited in two street surveys in 1990 and 1993. In the cohort, trends from 1986 through 1995 in injecting risk behaviour (as reported at entry) and in HIV seroconversion (among current IDUs during follow-up) were determined using logistic and Poisson regression.
Findings: Sizable portions of IDUs were young (< or = 25 years: 14-30%) or had recently started injecting (within the last 3 years: 17-21%). Between 37% and 50% of young IDUs recently started injecting. HIV prevalence was 12-24% among young IDUs, and 5-12% among recent-onset IDUs. Young IDUs more often reported current borrowing than older IDUs. Borrowing declined significantly in all subgroups, except young IDUs. The crude HIV incidence declined from 18/100 person-years (PY) in 1986 to 5/100 PY in 1995. Trends in HIV incidence were not significantly different for subgroups of age or onset of injecting. In a multivariate analysis, recent onset of injecting was an independent predictor (p = 0.04) for HIV seroconversion, but age was not (p = 0.68).
Conclusions: Important proportions of drug users are young or have recently started injecting. HIV prevalence is relatively high among young and recent-onset IDUs. Recent onset of injection is an independent predictor for HIV seroconversion. Our observations may be explained by non-random patterns of borrowing used needles/syringes. Recent-onset IDUs should be approached more actively for HIV counselling and testing.
Similar articles
-
[Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, I994-2002].Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2325-30. Ned Tijdschr Geneeskd. 2004. PMID: 15587051 Dutch.
-
Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.AIDS. 2006 Aug 22;20(13):1771-5. doi: 10.1097/01.aids.0000242824.59377.53. AIDS. 2006. PMID: 16931942
-
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.CMAJ. 2002 Apr 2;166(7):894-9. CMAJ. 2002. PMID: 11949985 Free PMC article.
-
HIV infection and injecting drug users: from epidemiology to public health.AIDS. 1990;4 Suppl 1:S105-9. AIDS. 1990. PMID: 2152552 Review. No abstract available.
-
Psychiatric comorbidity in injecting drug users in Asia and Africa.Curr Opin Psychiatry. 2012 May;25(3):213-8. doi: 10.1097/YCO.0b013e3283523d66. Curr Opin Psychiatry. 2012. PMID: 22449767 Review.
Cited by
-
Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.Drug Alcohol Rev. 2018 Mar;37(3):421-428. doi: 10.1111/dar.12667. Epub 2018 Feb 12. Drug Alcohol Rev. 2018. PMID: 29430806 Free PMC article.
-
Impact of length of injecting career on HIV incidence among people who inject drugs.Addict Behav. 2016 Jul;58:90-4. doi: 10.1016/j.addbeh.2016.02.020. Epub 2016 Feb 16. Addict Behav. 2016. PMID: 26921723 Free PMC article.
-
THE FIRST INJECTION EVENT: DIFFERENCES AMONG HEROIN, METHAMPHETAMINE, COCAINE, AND KETAMINE INITIATES.J Drug Issues. 2010 Spring;40(2):241-262. doi: 10.1177/002204261004000201. J Drug Issues. 2010. PMID: 21423792 Free PMC article.
-
Factors associated with adolescent initiation of injection drug use.Public Health Rep. 2001;116 Suppl 1(Suppl 1):136-45. doi: 10.1093/phr/116.S1.136. Public Health Rep. 2001. PMID: 11889281 Free PMC article.
-
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior.Harm Reduct J. 2022 Jun 2;19(1):58. doi: 10.1186/s12954-022-00642-4. Harm Reduct J. 2022. PMID: 35655222 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical